Five reasons to invest in the future of health.
A world leader in a fast-growing field
BICO is a world leader in bioconvergence and provides innovative and groundbreaking technologies, products and services that enable our customers to create the future of health with the help of Health 4.0. We expect good underlying market growth for many years to come, driven by demand for better technologies for pharmaceutical manufacturing.
Strong demand and high gross margins
There is strong demand for the Group’s products, and the share of revenue from consumables is increasing steadily. The Group companies have overall high gross margins*, 72.2 percent percent in 2021, the gross margin structure in acquired companies varies depending on the product mix, which means BICO is well positioned for long-term profitability. The business model gradually increases the share of recurring income in the form of services and consumables.
* Definition of gross margin on page 142 in our annual report , alternative key ratios.
Strong organic growth
Innovative R&D and an extensive IP portfolio